What is the 13F Pro Quality Score for MD?

13F Pro ranks Pediatrix Medical Group, Inc. (MD) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View MD's current score at https://13fpro.ai/research/MD (free sign-up required for the full ranking).

Where does 13F Pro source MD data?

All Pediatrix Medical Group, Inc. fundamentals and ownership data come directly from SEC EDGAR. Pediatrix Medical Group, Inc. files with the SEC under CIK 893949. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is MD in?

Pediatrix Medical Group, Inc. (MD) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is MD research updated on 13F Pro?

MD's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Pediatrix Medical Group, Inc.(MD)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSE

Institutional-grade research for retail investors

SEC EDGAR: CIK 893949 MD stock profile & AI dashboard →

13F Pro Quality Score

55.4/100

Rank #1,155 of 2,879 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

24.7/100

Profitability

74.6/100

Balance Sheet

79.0/100

Earnings Quality

85.9/100

Free Cash Flow

38.4/100

Institutional Flow

29.9/100

Revenue Scale

61.6/100

Dilution Risk

58.5/100

MD Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Pediatrix Medical Group, Inc. (MD), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MD at 55.4/100 on a 32-signal composite quality model, placing it at rank #1,155 of 2,879 stocks — the top half of the AI-ranked universe. MD scores in the top quartile across earnings quality (85.9), balance sheet strength (79.0). Areas of concern include revenue growth (24.7) and institutional flow (29.9), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Pediatrix Medical Group, Inc. reports quarterly revenue of $476.2M, net income of $29.6M, an operating margin of 8.8%. Top institutional holders of MD by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, AMERICAN CENTURY COMPANIES, based on the most recent SEC filings. MD trades on the NYSE exchange and files with the SEC under CIK 893949. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Pediatrix Medical Group, Inc. directly from SEC EDGAR. Pediatrix Medical Group, Inc.'s 13F Pro composite quality score has ranged between 8 and 65 since 2026, currently 55.4 — an improving long-term trajectory across 36 quarterly and live scoring snapshots.

✦

Fun facts about Pediatrix Medical Group, Inc.

Quirks, history, and lore behind MD — the kind of stuff that makes a stock memorable.

1
The Basics
A U.S. healthcare services company · mid-cap · listed on NYSE · headquartered in Florida.
2
The Numbers
Generates roughly $2 billion in annual revenue and employs thousands of physician clinicians across dozens of U.S. states.
3
The History
Founded in the late 1980s, it grew by consolidating a highly fragmented corner of medicine, building one of the largest physician group practices in the country.
4
The Secret
It doesn't run hospitals — it staffs them, specializing in outsourced physician services for hospital departments that need around-the-clock coverage.
5
The Lore
Its doctors focus almost entirely on the tiniest and most vulnerable patients — think neonatal intensive care units and newborn nurseries across America.
6
The Giveaway
The name literally spells out the mission: pediatric care, delivered by a national network of neonatologists and pediatric subspecialists under one corporate roof.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$476.2M

Net Income

Q1 2026

$29.6M

Free Cash Flow

Q1 2026

$-129.8M

Operating Margin

Q1 2026

8.8%

D/E Ratio

Q1 2026

0.67

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+0.9% YoY

$2.01BFY 2024

FY21 $1.91BFY22 $1.97BFY23 $1.99BFY24 $2.01B

Net Income

-64.0% YoY

$-99.1MFY 2024

FY21 $131.0MFY22 $66.3MFY23 $-60.4MFY24 $-99.1M

Operating Income

-1038.6% YoY

$-68.7MFY 2024

FY21 $202.9MFY22 $172.7MFY23 $7.3MFY24 $-68.7M

EPS (Diluted)

-63.0% YoY

$-1.19FY 2024

FY21 $1.53FY22 $0.79FY23 $-0.73FY24 $-1.19

Total Assets

-3.0% YoY

$2.15BFY 2024

FY21 $2.72BFY22 $2.35BFY23 $2.22BFY24 $2.15B

Total Debt

-0.8% YoY

$631.7MFY 2024

FY21 $992.2MFY22 $652.1MFY23 $637.1MFY24 $631.7M

Op. Cash Flow

+50.4% YoY

$206.6MFY 2024

FY21 $76.7MFY22 $166.9MFY23 $137.3MFY24 $206.6M

Metric	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Revenue	$2.01B +0.9%	$1.99B +1.1%	$1.97B +3.2%	$1.91B +10.2%	$1.73B -2.6%	$1.78B
Net Income	$-99.1M -64.0%	$-60.4M -191.1%	$66.3M -49.3%	$131.0M +116.4%	$-796.5M +46.8%	$-1.50B
Operating Income	$-68.7M -1038.6%	$7.3M -95.8%	$172.7M -14.9%	$202.9M +106.8%	$98.1M -42.9%	$171.8M
EPS (Diluted)	$-1.19 -63.0%	$-0.73 -192.4%	$0.79 -48.4%	$1.53 +116.0%	$-9.55 +46.4%	$-17.83
Total Assets	$2.15B -3.0%	$2.22B -5.5%	$2.35B -13.8%	$2.72B -18.7%	$3.35B -19.2%	$4.15B
Total Debt	$631.7M -0.8%	$637.1M -2.3%	$652.1M -34.3%	$992.2M -41.6%	$1.70B +0.0%	$1.70B
Operating Cash Flow	$206.6M +50.4%	$137.3M -17.7%	$166.9M +117.5%	$76.7M -62.5%	$204.6M -42.8%	$357.7M

Get alerted when MD's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Pediatrix Medical Group, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of MD

BlackRock, Inc.
$290.4M13,574,373 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$131.6M6,154,126 sh
AMERICAN CENTURY COMPANIES INC
$84.0M3,925,366 sh
DIMENSIONAL FUND ADVISORS LP
$82.5M3,856,915 sh
VICTORY CAPITAL MANAGEMENT INC
$82.2M3,841,933 sh
VANGUARD CAPITAL MANAGEMENT LLC
$78.2M3,656,321 sh
STATE STREET CORP
$72.3M3,378,500 sh
FMR LLC
$48.5M2,267,434 sh
GEODE CAPITAL MANAGEMENT, LLC
$46.8M2,187,967 sh
WASATCH ADVISORS LP
$43.9M2,050,524 sh

Fund	Value	Shares
BlackRock, Inc.	$290.4M	13,574,373
VANGUARD PORTFOLIO MANAGEMENT LLC	$131.6M	6,154,126
AMERICAN CENTURY COMPANIES INC	$84.0M	3,925,366
DIMENSIONAL FUND ADVISORS LP	$82.5M	3,856,915
VICTORY CAPITAL MANAGEMENT INC	$82.2M	3,841,933
VANGUARD CAPITAL MANAGEMENT LLC	$78.2M	3,656,321
STATE STREET CORP	$72.3M	3,378,500
FMR LLC	$48.5M	2,267,434
GEODE CAPITAL MANAGEMENT, LLC	$46.8M	2,187,967
WASATCH ADVISORS LP	$43.9M	2,050,524

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put MD on your watchlist

Track score changes the day Pediatrix Medical Group, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is MD a good stock to buy?

13F Pro's AI-powered analysis of Pediatrix Medical Group, Inc. (MD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MD are available on the MD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own MD?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Pediatrix Medical Group, Inc.'s investment landscape.